| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 19.07 | -0.06 (-0.31%) | 12.33 - 20.00 | 96.7 thousand (Below Avg) |
Market data as of 4:00PM 06/19/13. Quotes are delayed by at least 15 min.
| Open | 19.15 |
|---|---|
| Previous Close | 19.13 |
| Day's Range | 19.07 - 19.31 |
| Market Cap | 654.7M |
| Avg Volume (10 Day) | 133.3K |
| Price/Earnings (Trailing 12 Mo.) | 38.3x |
| Earnings Per Share (Trailing 12 Mo.) | 0.5 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings
PR Newswire - Wednesday 06/19/2013 8:07 AM ET
Baptist Memorial Health Care Selects Omnicell G4 Platform for Automated Medication Management
PR Newswire - Monday 06/03/2013 8:00 AM ET
| OMCL | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 33.45% | |
| Net Income Growth (1yr) | 42.60% | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | 2.61% | |
| Price/Sales | 1.95 |
| Company | Last | Change |
|---|---|---|
| Ruckus Wireless Inc | 12.04 | +5.52% |
| Radisys Corp | 5.06 | -0.39% |
| Concurrent Computer Corp | 7.91 | +1.15% |
| iGO Inc | 2.39 | -0.42% |
| Lexmark International Inc | 30.69 | -0.84% |
Data is delayed by at least 15 min.